Jon Congleton, CEO: Mineralys Therapeutics MLYS Sell · Filed 24/10/15

Trade details

Type: Insider sale
Amount: $206,463.92
Shares · price: 15,271 sh · $13.52 a share
Held after: 895,941 sh
Stock: Mineralys Therapeutics MLYS
Person: Jon CongletonCEO
Trade date: 24/10/11
Filed: 24/10/15
Days to filing: 4 days

Sold 1.7% of holdings

Share of holding sold: 1.7%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 24/09/11~24/11/10

Jon Congleton's recent trades

Jon CongletonCEO
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$1.9M
75,000 sh
$1.9M
Filed 09/30
Traded 09/30
Jon CongletonCEO
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$291.4K
10,700 sh
$291.4K
Filed 07/13
Traded 07/13
Jon CongletonCEO
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$1.5M
58,000 sh
$1.5M
Filed 06/30
Traded 06/30
Jon CongletonCEO
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$455.9K
17,000 sh
$455.9K
Filed 06/30
Traded 06/30
Jon CongletonCEO
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$2M
75,000 sh
$2M
Filed 06/30
Traded 06/30